News

Candesic provided vendor commercial due diligence to Hakim Group

23 May 25

Hakim Group, the UK’s largest independent group of opticians and audiologists, announced yesterday it is partnering with Intermediate Capital Group (ICG). Hakim Group has built a strong platform of clinically led, community-focused practices and continues to redefine excellence.Candesic is ...

Candesic provided commercial due diligence to Keys Group

23 May 25

Keys Group has acquired ADHD 360, a fast-growing provider of ADHD assessment and treatment services across the UK. ADHD 360 delivers evidence-based, personalised care to individuals of all ages and has built a strong reputation for quality and accessibility in the neurodevelopmental space. The ...

Aldous Mitchell explores the evolving transatlantic healthcare investment landscape

20 May 25

As the U.S. introduces sweeping tariff reforms and redefines global trade dynamics, Aldous Mitchell, Partner at Candesic, highlights how these shifts are reshaping strategies for life sciences firms across the U.S. and Europe in the May edition of LaingBuisson’s HealthcareMarkets.The U.S. ...

Candesic and DAC Beachcroft co-host a roundtable event to explore how technology is shaping the future of care delivery

14 May 25

Candesic was delighted to co-host a roundtable event with DAC Beachcroft in April, bringing together leaders in the elderly care sector to explore how technology is shaping the future of care delivery.The event featured a keynote from Prof Martin Green, Chief Executive of Care England, ...

Aldous Mitchell shares insights on EQT’s planned sale of AGS Health and the growing appeal of RCM to private equity.

9 May 25

Aldous Mitchell, USA Partner at Candesic, shares insights with Healthcare Business International on EQT’s planned sale of AGS Health and the growing appeal of revenue cycle management (RCM) to private equity.He highlights RCM’s value in improving compliance, reducing leakage, and even ...

Candesic provided vendor commercial due diligence to FibroFind

8 May 25

Vespa Capital has announced its investment in FibroFind, a globally recognised pre-clinical contract research organisation. FibroFind has developed a unique, patented Precision Cut Tissue Slice (PCTS) platform, which offers significantly enhanced translational accuracy compared to traditional ...

Dr Leonid Shapiro on Fremman’s Amethyst Deal and the Future of European Radiotherapy

2 May 25

Dr Leonid Shapiro, Managing Partner at Candesic, shares insights with Healthcare Business International on Fremman Capital’s acquisition of Amethyst Healthcare Group and what it signals for Europe’s radiotherapy sector.He highlights growing consolidation in a fragmented market and how new ...

Dr Michelle Tempest and Dr Iham Kasem address children’s mental health services

1 May 25

Senior Partner at Candesic, Dr Michelle Tempest, and Associate Dr Iham Kasem address children’s mental health services in April’s edition of LaingBuisson HealthcareMarkets. It highlights a 16% drop in inpatient mental health beds, which is stark.An estimated 20% of 8 to 16-year-olds in ...

Fabio Ruffinoni shares insights with Healthcare Business International on Luz Saúde’s potential €1bn stake sale

1 May 25

Fabio Ruffinoni, Engagement Manager at Candesic, shares insights with Healthcare Business International on Luz Saúde’s potential €1bn stake sale and what it signals for Portugal’s healthcare market.Despite a broader M&A slowdown, Fabio explains why private healthcare in Portugal ...

Candesic named Commercial Due Diligence Provider of the Year

1 May 25

We are honoured to be named Commercial Due Diligence Provider of the Year at the Real Deals Private Equity Awards 2025! A huge thank you to our clients, partners, and the judging panel – this win is shared with all of you. And congratulations to the other winners and nominees!We continue our ...